Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. HCA
HCA logo

HCA Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
438.000
Open
433.450
VWAP
434.87
Vol
1.60M
Mkt Cap
96.54B
Low
431.420
Amount
695.48M
EV/EBITDA(TTM)
9.41
Total Shares
221.84M
EV
146.49B
EV/OCF(TTM)
11.27
P/S(TTM)
1.33
HCA Healthcare, Inc. is a health care services company. The Company provides acute care hospitals, ambulatory surgery centers (ASCs), freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, comprehensive rehabilitation and physical therapy centers, hospices, and various other facilities. Its general, acute care hospitals provide a full range of services to accommodate such medical specialties as internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics, as well as diagnostic and emergency services. Its behavioral hospitals provide a full range of mental health care services through inpatient, partial hospitalization and outpatient settings. It operates approximately 190 hospitals comprised of 179 general acute care hospitals, seven behavioral hospitals, and four rehabilitation hospitals and its facilities are in 19 states and the United Kingdom.
Show More

Events Timeline

(ET)
2026-04-27
08:30:00
HCA Healthcare Proposes Senior Notes Offering for Debt Repayment
select

News

Yahoo Finance
9.5
05-02Yahoo Finance
HCA Healthcare Q1 2026 Results: Market Reaction and Key Insights
  • Earnings Overview: HCA Healthcare reported Q1 2026 revenue of $19.11 billion, matching Wall Street expectations with a 4.3% year-on-year growth; however, a 42% drop in patient admissions due to a milder respiratory season and severe winter storm led to a negative market reaction.
  • EBITDA Shortfall Reasons: Management indicated that the primary drivers behind the EBITDA miss were lower seasonal volumes and winter storm impacts, which were mostly offset by higher-than-expected benefits from state Medicaid supplemental programs, yet overall performance remained under pressure.
  • Future Outlook: The management emphasized that in the upcoming quarters, they will closely monitor the approval of the Florida Medicaid supplemental program and its potential revenue impact, alongside the execution of HCA's $400 million cost-saving initiatives driven by AI.
  • Network Expansion and Acquisitions: CEO Hazen noted a strong pipeline of outpatient acquisition projects, which are expected to drive sustainable growth, despite ongoing uncertainties in payer mix and trends in uninsured patients.
Newsfilter
5.0
04-27Newsfilter
HCA Healthcare Appoints New SVP of Marketing and Corporate Affairs
  • Executive Appointment: HCA Healthcare announced that Cynthia Cifuentes-Finkel will become the Senior Vice President of Marketing and Corporate Affairs effective June 8, 2026, leading enterprise marketing, corporate communications, and stakeholder engagement to support the company's growth priorities.
  • Extensive Experience: Cifuentes-Finkel brings over 25 years of executive leadership experience, including 15 years in senior roles at Kaiser Permanente, where she recently served as Regional Vice President of Communications and Strategic Partnerships for Southern California and Hawaii, overseeing nearly 5 million patients and demonstrating her ability to drive enterprise growth in complex environments.
  • Brand and Strategy Enhancement: Throughout her career, she has successfully advanced brand and stakeholder strategies, driving enterprise growth and transformative community investments across multiple markets, particularly through innovative clinical partnerships and AI integration, showcasing her significant impact in the healthcare sector.
  • Succession and Well Wishes: Cifuentes-Finkel succeeds Deb Reiner, who has served HCA Healthcare for over 25 years and played a vital role in shaping the company's branding and corporate affairs strategy, with leadership expressing gratitude for Reiner's contributions and wishing her well in retirement.
Newsfilter
9.5
04-27Newsfilter
HCA Healthcare Q1 Earnings Meet Expectations Amid Dynamic Environment
  • Earnings Meet Expectations: HCA Healthcare's Q1 earnings report indicates that both revenue and profit align with market expectations, reflecting the company's stable performance in a dynamic environment, which bolsters investor confidence in its future growth.
  • CEO Commentary: The CEO highlighted that despite uncertainties, HCA Healthcare has managed to maintain operational stability, indicating the company's resilience and adaptability in navigating market changes.
  • Analyst Ratings Maintained: While HCA Healthcare's performance met expectations, analysts have maintained their ratings but generally lowered price targets, reflecting a cautious outlook on future growth prospects.
  • Dynamic Market Environment: HCA Healthcare's performance is viewed as a significant indicator within the healthcare sector, potentially influencing investor confidence and decision-making across the broader medical industry amid ongoing challenges and changes.
seekingalpha
8.5
04-27seekingalpha
HCA Healthcare Proposes Senior Notes Offering
  • Senior Notes Offering: HCA Healthcare's wholly owned subsidiary, HCA Inc, has proposed a senior notes offering, with actual terms contingent on market conditions, indicating the company's adaptability in capital markets.
  • Clear Use of Proceeds: HCA Inc intends to utilize the net proceeds for general corporate purposes, a move that not only enhances the company's financial flexibility but may also support future strategic investments.
  • Positive Market Reaction: Following the announcement, HCA's stock rose 0.6% in premarket trading to $435.0, reflecting investor confidence in the company's outlook.
  • Stable Growth Outlook: HCA projects a volume growth of 2% to 3% over the coming years, despite facing an exchange headwind of $600 million to $900 million, demonstrating the company's resilience in uncertain environments.
Newsfilter
8.5
04-27Newsfilter
HCA Healthcare Proposes Senior Notes Offering
  • Offering Proposal: HCA Healthcare's wholly owned subsidiary, HCA Inc., proposes to issue senior notes, with actual terms contingent on market conditions, indicating the company's active engagement in capital markets and financing flexibility.
  • Use of Proceeds: The net proceeds from this offering will be utilized for general corporate purposes, including the repayment of up to $4.000 billion in outstanding borrowings under its commercial paper program, aimed at optimizing the company's capital structure and reducing financial costs.
  • Debt Management: HCA Inc. plans to use a portion of the proceeds to redeem $1.500 billion of its 5.250% senior notes due June 2026 and $1.000 billion of its 5.375% senior notes due September 2026, which will help lower interest expenses and improve cash flow.
  • Underwriter Consortium: The offering is being managed by Citigroup, Barclays Capital, BofA Securities, and J.P. Morgan Securities, reflecting strong market confidence in HCA and potentially enhancing the likelihood of a successful issuance.
NASDAQ.COM
4.5
04-24NASDAQ.COM
US Stocks Close Higher: S&P 500 Hits All-Time High
  • S&P 500 Hits Record High: The S&P 500 index rose by 0.80%, closing at an all-time high, reflecting market optimism about economic recovery, particularly driven by technology stocks, which further solidifies investor confidence.
  • Intel's Strong Performance: Intel's stock surged over 23% after forecasting Q2 revenue between $13.8 billion and $14.8 billion, significantly exceeding the $13.04 billion expectation, indicating strong confidence in the semiconductor industry's potential driven by artificial intelligence, which may spark increased investment in the sector.
  • Consumer Confidence Rebounds: The University of Michigan's consumer sentiment index was revised upward to 49.8, surpassing the expected 48.5, suggesting an increase in consumer confidence regarding economic prospects, which could drive consumer spending and economic growth.
  • International Dynamics Affecting Markets: Progress in US-Iran negotiations has boosted market sentiment; despite tensions in the Strait of Hormuz, optimism about future talks may alleviate energy price pressures and promote stock market gains.
Wall Street analysts forecast HCA stock price to rise
19 Analyst Rating
Wall Street analysts forecast HCA stock price to rise
13 Buy
5 Hold
1 Sell
Moderate Buy
Current: 0.000
sliders
Low
420.00
Averages
491.89
High
525.00
Current: 0.000
sliders
Low
420.00
Averages
491.89
High
525.00
Bernstein
Market Perform
downgrade
$541 -> $503
AI Analysis
2026-04-28
Reason
Bernstein
Price Target
$541 -> $503
AI Analysis
2026-04-28
downgrade
Market Perform
Reason
Bernstein lowered the firm's price target on HCA Healthcare to $503 from $541 and keeps a Market Perform rating on the shares. The firm modestly lowers 2027 and beyond EBITDA forecasts and remains more moderate in EBITDA growth expectation with CAGR of 5.1%. Bernstein sees slowing state supplemental payments, and risks from insurance coverage reductions and potential bad debt growth. Operating execution is strong and margins remain well controlled, which can offset some of these challenges, adds the firm.
BofA
Neutral
downgrade
$540 -> $480
2026-04-27
Reason
BofA
Price Target
$540 -> $480
2026-04-27
downgrade
Neutral
Reason
BofA lowered the firm's price target on HCA Healthcare to $480 from $540 and keeps a Neutral rating on the shares. The firm is "generally more cautious" on hospitals given the policy headwinds and slowing fundamentals, but views HCA as "relatively better positioned to manage through those headwinds" than peers, the analyst tells investors.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for HCA
Unlock Now

Valuation Metrics

The current forward P/E ratio for HCA Healthcare Inc (HCA.N) is 14.08, compared to its 5-year average forward P/E of 14.11. For a more detailed relative valuation and DCF analysis to assess HCA Healthcare Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
14.11
Current PE
14.08
Overvalued PE
15.61
Undervalued PE
12.62

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
9.09
Current EV/EBITDA
9.04
Overvalued EV/EBITDA
9.67
Undervalued EV/EBITDA
8.52

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
1.18
Current PS
1.16
Overvalued PS
1.32
Undervalued PS
1.04

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

just narrow to stocks below fair value
Intellectia · 516 candidates
Region: USVolume: >= 0Market Cap Category: mega, large, mid, small, micro, nanoPe Ttm: 5 - 18List Exchange: XNYS, XNASPs Ratio: <= 5.00P/B Ratio: <= 3.00P Fcf Ratio: <= 18.00Weekly Average Dollar Volume: >= 0Monthly Average Dollar Volume: >= 0Ev Ebitda: <= 15
Ticker
Name
Market Cap$
top bottom
VZ logo
VZ
Verizon Communications Inc
196.33B
COP logo
COP
ConocoPhillips
141.44B
T logo
T
AT&T Inc
185.10B
CMCSA logo
CMCSA
Comcast Corp
106.60B
DAL logo
DAL
Delta Air Lines Inc
47.12B
UAL logo
UAL
United Airlines Holdings Inc
33.05B
what buy today
Intellectia · 64 candidates
Net Margin: >= 10.00Pe Ttm: 10 - 35Moving Average Relationship: PriceAboveMA200Is Index Component: GSPC, DJI, NDXAnnual Revenue Yoy Growth: >= 5.0%
Ticker
Name
Market Cap$
top bottom
AAPL logo
AAPL
Apple Inc
3.75T
GOOG logo
GOOG
Alphabet Inc
3.57T
JNJ logo
JNJ
Johnson & Johnson
587.99B
MU logo
MU
Micron Technology Inc
414.84B
AZN logo
AZN
AstraZeneca PLC
311.30B
CSCO logo
CSCO
Cisco Systems Inc
307.82B
cosa conviene comprare ora su plus500
Intellectia · 97 candidates
Market Cap: >= 10.00BBeta: LowRisk, ModerateRiskPe Ttm: 10 - 25Moving Average Relationship: PriceAboveMA200Is Index Component: GSPC
Ticker
Name
Market Cap$
top bottom
BRK.B logo
BRK.B
Berkshire Hathaway Inc
1.06T
XOM logo
XOM
Exxon Mobil Corp
650.52B
CVX logo
CVX
Chevron Corp
392.73B
KO logo
KO
Coca-Cola Co
332.62B
MRK logo
MRK
Merck & Co Inc
285.83B
GS logo
GS
Goldman Sachs Group Inc
232.12B
which stock to buy todat
Intellectia · 62 candidates
Market Cap: >= 10.00BMarket Cap Category: mega, largeNet Margin: >= 10.00Pe Ttm: 10 - 30Moving Average Relationship: PriceAboveMA20Monthly Average Dollar Volume: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
COP logo
COP
ConocoPhillips
143.10B
HCA logo
HCA
HCA Healthcare Inc
119.15B
ENB logo
ENB
Enbridge Inc
117.95B
ADBE logo
ADBE
Adobe Inc
115.61B
CME logo
CME
CME Group Inc
113.72B
NOC logo
NOC
Northrop Grumman Corp
107.31B
give me top 5 screener
Intellectia · 62 candidates
Region: USMarket Cap Category: large, megaNet Margin: >= 10.00Eps 5yr Cagr: >= 10Pe Ttm: 10 - 35Moving Average Relationship: PriceAboveMA200Is Index Component: GSPC
Ticker
Name
Market Cap$
top bottom
GOOG logo
GOOG
Alphabet Inc
3.70T
JPM logo
JPM
JPMorgan Chase & Co
823.62B
JNJ logo
JNJ
Johnson & Johnson
586.69B
MU logo
MU
Micron Technology Inc
463.33B
BAC logo
BAC
Bank of America Corp
379.02B
CAT logo
CAT
Caterpillar Inc
362.31B
biggest earners today
Intellectia · 14 candidates
Market Cap: >= 500.00MPrice: >= $3.00Price Change Pct: >= $10.00List Exchange: XNYS, XNAS, XASEIs Optionable: TrueMonthly Average Dollar Volume: >= 500,000
Ticker
Name
Market Cap$
top bottom
RR logo
RR
Richtech Robotics Inc
835.65M
RDW logo
RDW
Redwire Corp
1.79B
HUYA logo
HUYA
HUYA Inc
846.71M
SATL logo
SATL
Satellogic Inc
592.67M
GLW logo
GLW
Corning Inc
81.28B
NET logo
NET
Cloudflare Inc
66.96B

Whales Holding HCA

A
Abrams Bison Investments, L.L.C.
Holding
HCA
+21.34%
3M Return
B
Bridgewater Associates
Holding
HCA
+15.50%
3M Return
I
IMC Trading B.V.
Holding
HCA
+13.21%
3M Return
C
Cbus Industry Superannuation Fund
Holding
HCA
+12.64%
3M Return
Y
Yarbrough Capital, LLC
Holding
HCA
+12.51%
3M Return
M
Motley Fool Asset Management, LLC
Holding
HCA
+12.00%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is HCA Healthcare Inc (HCA) stock price today?

The current price of HCA is 435.19 USD — it has increased 1.44

What is HCA Healthcare Inc (HCA)'s business?

HCA Healthcare, Inc. is a health care services company. The Company provides acute care hospitals, ambulatory surgery centers (ASCs), freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, comprehensive rehabilitation and physical therapy centers, hospices, and various other facilities. Its general, acute care hospitals provide a full range of services to accommodate such medical specialties as internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics, as well as diagnostic and emergency services. Its behavioral hospitals provide a full range of mental health care services through inpatient, partial hospitalization and outpatient settings. It operates approximately 190 hospitals comprised of 179 general acute care hospitals, seven behavioral hospitals, and four rehabilitation hospitals and its facilities are in 19 states and the United Kingdom.

What is the price predicton of HCA Stock?

Wall Street analysts forecast HCA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HCA is491.89 USD with a low forecast of 420.00 USD and a high forecast of 525.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is HCA Healthcare Inc (HCA)'s revenue for the last quarter?

HCA Healthcare Inc revenue for the last quarter amounts to 19.11B USD, increased 4.30

What is HCA Healthcare Inc (HCA)'s earnings per share (EPS) for the last quarter?

HCA Healthcare Inc. EPS for the last quarter amounts to 7.15 USD, increased 10.85

How many employees does HCA Healthcare Inc (HCA). have?

HCA Healthcare Inc (HCA) has 230000 emplpoyees as of May 11 2026.

What is HCA Healthcare Inc (HCA) market cap?

Today HCA has the market capitalization of 96.54B USD.